1. World Health Organisation. Cardiovascular diseases (CVDs). 2017.2017. Available at: https://www.who.int/ru/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

2. National Institute for Health and Care Excellence. Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis. Clinical guideline. 2010.Available at: https://www.nice.org.uk/guidance/cg95

3. Montalescot G, Sechtem W, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;34(38):2949–3003. DOI: 10.1093/eurheartj/eht296

4. Jones E, Eteiba W, Merz NB. Cardiac Syndrome X and Microvascular Coronary Dysfunction. Trends in Cardiovascular Medicine. 2012;22(6):161–8. DOI: 10.1016/j.tcm.2012.07.014

5. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126(25):3097–137. DOI: 10.1161/CIR.0b013e3182776f83

6. National Institute for Health and Care Excellence. Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis. Final version. NICE guideline CG95. Methods, evidence and recommendations. Av. at: https://www.nice.org.uk/guidance/cg95/evidence/fullguideline-245282221. 2016.

7. Di Fiore DP, Beltrame JF. Chest pain in patients with ‘normal angiography’: could it be cardiac? International Journal of Evidence- Based Healthcare. 2013;11(1):56–68. DOI: 10.1111/1744-1609.12002

8. National Institute for Health and Clinical Excellence. Stable angina: management. Clinical guideline. 23 July 2011. Last updated: 25 August 2016.Available at: https://www.nice.org.uk/guidance/cg126

9. Tarkin JM, Kaski JC. Pharmacological treatment of chronic stable angina pectoris. Clinical Medicine. 2013;13(1):63–70. DOI: 10.7861/clinmedicine.13-1-63

10. Divchev D, Stöckl G. Treatment of Stable Angina with a New FixedDose Combination of Ivabradine and Metoprolol: Effectiveness and

11. olerability in Routine Clinical Practice. Cardiology and Therapy. 2017;6(2):239–49. DOI: 10.1007/s40119-017-0099-1

12. Werdan K, Ebelt H, Nuding S, Höpfner F, Stöckl G, Müller-Werdan U et al. Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial. Cardiology. 2016;133(2):83–90. DOI: 10.1159/000439584

13. Zarifis J, Kallistratos M, Katsivas A, on behalf of the investigators of the Prospective, Non-interventional, Observational Study of the Antianginal Efficacy of Ivabradine During a 4-Month Treatment of a Greek Population With Coronary Artery Disease. Antianginal Efficacy of Ivabradine/Metoprolol Combination in Patients With Stable Angina. Clinical Cardiology. 2016;39(12):697–702. DOI: 10.1002/clc.22585

14. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M et al. ROBINS-I: a tool for assessing risk of bias in nonrandomised studies of interventions. BMJ. 2016;355:i4919. DOI: 10.1136/bmj.i4919

15. Reeves BC, Deeks JJ, Higgins JPT, Shea B, Tugwell P, Wells GA. Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020.Available at: https://training.cochrane.org/handbook/current/chapter-24